The Economic Burden of Diabetic Retinopathy in Jordan: Cost Analysis and Associated Factors.
Rami A Al-DwairiAbdelwahab AleshawiLaith Abu-ZreigWafa Al-ShormanSeren Al BeirutiAli Omar AlshamiMohammed Z AllouhPublished in: ClinicoEconomics and outcomes research : CEOR (2024)
This study is the first study to be conducted in Jordan and encourages us to establish a screening program for DR for earlier detection and treatment. DM control and treatment compliance will reduce the heavy costs of the already exhausted healthcare and financial system.